Clinical Trials Sponsored by Point Designs

Total 548 results

Point Designs
University of Colorado, Boulder

Completed

Teleoperation Experimental Comparison With Able-bodied Subjects

Amputation; Traumatic, Arm, Upper

United States
Point Designs
University of Colorado, Denver

Completed

Validation of User Needs of the Point Digit With Partial Hand Amputees

Amputation; Traumatic, Hand

United States
Point Designs
University of Colorado, Denver

Completed

Validation of Point Partial User Needs With Partial Finger Amputees

Amputation; Traumatic, Hand

United States
Point Designs
University of Colorado, Denver; Arm Dynamics

Completed

To Assess the Utility of the Point Digit in a Clinical Take-home Study

Amputation; Traumatic, Hand

United States
Point Designs
University of Colorado, Denver; Arm Dynamics

Completed

To Assess the Utility of the Point Partial in a Clinical Take-home Study of Partial Hand Amputees

Amputation; Traumatic, Hand

United States
Innovative Surgical Designs

Suspended

Pedicle Osteotomy for Stenosis Trial (POST)

Lumbar Spinal Stenosis | Spondylolisthesis, Grade 1 | Neurogenic Claudication

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Coronary Artery Disease

United States
Point Biomedical

Completed

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease (POINT II)

Coronary Artery Disease

United States
Point Biomedical

Completed

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

Coronary Artery Disease | Healthy

United States
Point Therapeutics

Completed

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Point Therapeutics

Terminated

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, Pulmonary

United States
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Point Therapeutics

Terminated

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Adenocarcinoma | Neoplasm Metastasis | Pancreatic Cancer

United States
Designs for Health

Recruiting

A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health

Oral Health

United States
Phoenix Molecular Designs

Active, not recruiting

Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer | Triple Negative Breast Cancer

United States
POINT Biopharma

Active, not recruiting

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Soft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)

United States, Canada
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Coronary Artery Disease

United States
Point Biomedical

Terminated

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

Coronary Artery Disease | Healthy

United States
Point Therapeutics

Completed

Study of Talabostat and Cisplatin in Advanced Melanoma

Melanoma | Skin Cancer

United States
Point Therapeutics

Completed

Study of Talabostat in Advanced Melanoma

Melanoma | Skin Cancer

United States
High Point University

Recruiting

The Effect of Combining Pain Neuroscience Education and Transcranial Direct Current Stimulation on Pain Catastrophizing, Kinesiophobia, and Pain in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Catastrophizing Pain | Kinesiophobia

United States
Design Therapeutics

Completed

Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia

Friedreich Ataxia

United States
Immune Design

Terminated

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Melanoma | Sarcoma | Ovarian Cancer | Non-small Cell Lung Cancer

United States
High Point University

Terminated

The Diagnostic Accuracy of the Clinical Examination

Musculoskeletal Pain | Musculoskeletal Injury

United States
High Point University

Completed

Real-time Optimized Biofeedback Utilizing Sport Techniques (ROBUST)

Knee Injuries
High Point University

Completed

Utilizing the Trunk as a Proximal Lever to Strengthen the Hip Musculature and Alter Lower Extremity Function

Patellofemoral Pain Syndrome

United States
High Point University

Completed

Conservative Management of Femoroacetabular Impingement

Femoroacetabular Impingement

United States
High Point University

Completed

Do Common Physical Tests Predict Injury or Performance (TEAM)

Lower Extremity Musculoskeletal Injury

United States
Cell>Point LLC

Completed

A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)

Coronary Artery Disease

United States
Cell>Point LLC

Unknown

Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)

Coronary Artery Disease

United States
Cell>Point LLC

Active, not recruiting

A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer

Lung Cancer

United States
High Point University

Completed

Benefits of Traditional and Golf-specific Resistance Training in Amateur Female Golfers

Improved Performance in Amateur Female Golfers (MESH Term: Body Composition)

United States
High Point University

Completed

Neurocognitive Visual Reaction Training

Reaction Time

United States
Immune Design

Terminated

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Sarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic Sarcoma

United States, Canada
Immune Design

Completed

A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

Merkel Cell Carcinoma

United States
Immune Design

Completed

A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer

Melanoma | Sarcoma | Breast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer

United States
Abbott Point of Care

Not yet recruiting

Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood

Potassium (K) and Ionized Calcium (iCa) in Capillary Whole Blood
Zero Point Five Therapeutics

Not yet recruiting

Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

Soil-Transmitted Helminthiasis (STH)

Brazil, Ghana
Turning Point Therapeutics, Inc.

Recruiting

A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

Advanced Solid Tumor | Metastatic Solid Tumor

United States
Oyster Point Pharma, Inc.

Terminated

A Study Evaluating the Safety of the Nasal Pump

Dry Eye | Kerato Conjunctivitis Sicca

United States
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)

Dry Eye Disease

United States
Oyster Point Pharma, Inc.

Completed

Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease (DED)

United States
High Point Pharmaceuticals, LLC.

Terminated

A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects

Obesity | Overweight

United States
Abbott Point of Care

Not yet recruiting

Precision Study Measuring Potassium (K) in Capillary Specimens

Precision of Potassium (K) Test in Capillary Whole Blood
Abbott Point of Care

Active, not recruiting

Abbott i-STAT High Sensitivity Troponin I Study (i-STAT hs-TnI)

Myocardial Infarction

United States
Monash University
Turning Point

Completed

Brain Exercise and Addiction Trial (BEAT)

Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe

Australia
Turning Point Therapeutics, Inc.

Withdrawn

A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Metastatic Solid Tumor | Locally Advanced Solid Tumor

United States, Spain

3

Subscribe